FDA Approves Nasal Influenza Vaccine for Use in Younger Children
FDA Approves Nasal Influenza Vaccine for Use in Younger Children
The U.S. Food and Drug Administration today approved expanding the population for use of the nasal influenza vaccine FluMist to include children between the ages of 2 and 5.